These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1594239)

  • 21. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
    Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
    Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.
    Davis M; Hitchcock A; Foulkes WD; Campbell IG
    Cancer Res; 1996 Feb; 56(4):741-4. PubMed ID: 8631007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allele loss from chromosome 17 in ovarian cancer.
    Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ
    Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
    Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
    Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
    Brewster SF; Browne S; Brown KW
    J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.
    Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI
    Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
    Murty VV; Li RG; Houldsworth J; Bronson DL; Reuter VE; Bosl GJ; Chaganti RS
    Oncogene; 1994 Nov; 9(11):3227-31. PubMed ID: 7936646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
    Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
    Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
    Amfo K; Neyns B; Teugels E; Lissens W; Bourgain C; De Sutter P; Vandamme B; Vamos E; De Grève J
    Oncogene; 1995 Jul; 11(2):351-8. PubMed ID: 7624149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction.
    Cho JH; Noguchi M; Ochiai A; Hirohashi S
    Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung].
    Shao S; Sun W; Zhang J; An Q; Xiao T; Yang P; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):740-2. PubMed ID: 12126542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
    Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
    Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
    Cairns P; Proctor AJ; Knowles MA
    Oncogene; 1991 Dec; 6(12):2305-9. PubMed ID: 1766677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Fukunari H; Tanaka K; Miyaki M
    Cancer Res; 1992 Jul; 52(13):3801-3. PubMed ID: 1319833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
    Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
    Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.